Alopecia Areata Market Growth Forecast: Market Size, Key Trends And Emerging Opportunities Through 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Alopecia Areata Market Size Forecast: How Big Could The Market Get By 2030?
The alopecia areata market size has demonstrated strong expansion in recent years. It is anticipated to increase from $3.81 billion in 2025 to $4.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. The growth witnessed in the historical period can be attributed to the rising global prevalence of alopecia areata, previously limited treatment options, increasing demand for dermatology care, the development of hospital and specialty clinic infrastructure, and the adoption of traditional herbal and natural remedies.
The alopecia areata market size is projected to experience significant expansion in the coming years. It is anticipated to reach $5.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This growth during the forecast period can be primarily attributed to the advancement of novel immunotherapy drugs, increased investment in dermatology research, a growing preference for personalized hair loss treatments, the expansion of homecare and teledermatology services, and an increase in clinical trials for hair regrowth. Significant trends expected in the forecast period include a heightened awareness of autoimmune hair disorders, the rising adoption of topical and oral therapies, the proliferation of specialized clinics and homecare solutions, enhancements in trichoscopy and diagnostic techniques, and growing research into innovative hair regrowth treatments.
Get A Free Sample Report With In-Depth Market Insights:
Alopecia Areata Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of alopecia is projected to fuel the expansion of the alopecia areata market moving forward. Alopecia signifies the partial or complete absence of hair, commonly on the scalp but possibly in other bodily regions as well. The escalating incidence of alopecia is predominantly attributed to an uptick in autoimmune disorders, heightened levels of stress, inherent genetic susceptibility, and environmental factors that disrupt normal hair-follicle operation. Alopecia areata treatments aim to alleviate this increasing burden by targeting immune-mediated follicular inflammation, encouraging hair regrowth, and enhancing patient quality of life through more effective and faster-acting therapeutic alternatives. For instance, in July 2023, data from an article published by the U.S. Department of Health and Human Services indicated that over 50 Mn men and 30 Mn women in the U.S. are estimated to be affected by androgenetic alopecia each year. Therefore, the rising incidence of alopecia is driving the growth of the alopecia areata market.
Alopecia Areata Market Segment Outlook: Which Categories Are Growing Fastest?
The alopecia areata market covered in this report is segmented –
1) By Type: Patchy Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Diffuse Alopecia Areata, Ophiasis Alopecia
2) By Diagnosis: Trichoscopy, Skin Biopsy, Other Diagnoses
3) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration
4) By End-Users: Hospitals, Specialty Clinics
Alopecia Areata Market Growth Trends Reshaping The Competitive Landscape
Leading firms within the alopecia areata market are prioritizing the authorization of novel medications, specifically Janus kinase (JAK) inhibitors, to enhance their standing and provide advanced treatment options. These JAK inhibitors function by impeding particular enzymes (JAK1/JAK2) implicated in the autoimmune mechanism that targets hair follicles, thus encouraging hair restoration for individuals suffering from severe alopecia areata. As an illustration, in June 2023, Pfizer Inc., a US-based biotechnology and pharmaceutical firm, revealed that the US Food and Drug Administration (FDA), the federal agency of the Department of Health and Human Services safeguarding public health in the US, had granted approval to LITFULOTM (ritlecitinib). This marks the initial and sole treatment for severe alopecia areata sanctioned for patients aged 12 and above. This medication is a once-daily oral therapy for alopecia areata, an autoimmune disorder for which, until recently, there were no FDA-approved treatments available for adolescents and limited choices for adults. LITFULO functions as a kinase inhibitor, targeting Janus kinase 3 (JAK3) and the tyrosine kinase family of kinases, including those associated with TEC.
Alopecia Areata Market Leading Companies And Competitive Benchmarking
Major companies operating in the alopecia areata market are Pfizer Inc., Eli Lilly and Company, Incyte Corporation, AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb, GlaxoSmithKline plc, Aclaris Therapeutics Inc., Almirall SA, Lupin Ltd., Sun Pharmaceutical Industries Ltd., Cipla Ltd., Glenmark Pharmaceuticals Ltd., Dr Reddys Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals, Arena Pharmaceuticals, AnaptysBio Inc., Viela Bio, Priovant Therapeutics
View The Full Alopecia Areata Market Report:
Alopecia Areata Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the alopecia areata market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the alopecia areata market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
